SEC Form 4 · accession 0001106578-26-000138
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairperson & CEO · Director
Period of report
Sep 9, 2026
Accepted (ET)
Sep 10, 2026 · 4:31 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Sep 9, 2026 | M | 9,500 | $117.76 | A | 333,943 | I | by Trust |
| Common StockF3,F2 | Sep 9, 2026 | S | 80 | $493.8058 | D | 333,863 | I | by Trust |
| Common StockF4,F2 | Sep 9, 2026 | S | 1,202 | $495.6529 | D | 332,661 | I | by Trust |
| Common StockF5,F2 | Sep 9, 2026 | S | 1,278 | $496.7266 | D | 331,383 | I | by Trust |
| Common StockF6,F2 | Sep 9, 2026 | S | 160 | $497.5575 | D | 331,223 | I | by Trust |
| Common StockF7,F2 | Sep 9, 2026 | S | 400 | $498.8486 | D | 330,823 | I | by Trust |
| Common StockF8,F2 | Sep 9, 2026 | S | 519 | $499.7341 | D | 330,304 | I | by Trust |
| Common StockF9,F2 | Sep 9, 2026 | S | 361 | $500.8393 | D | 329,943 | I | by Trust |
| Common StockF10,F2 | Sep 9, 2026 | S | 1,017 | $502.8653 | D | 328,926 | I | by Trust |
| Common StockF11,F2 | Sep 9, 2026 | S | 1,144 | $503.604 | D | 327,782 | I | by Trust |
| Common StockF12,F2 | Sep 9, 2026 | S | 964 | $505.0283 | D | 326,818 | I | by Trust |
| Common StockF13,F2 | Sep 9, 2026 | S | 875 | $505.7823 | D | 325,943 | I | by Trust |
| Common StockF14,F2 | Sep 9, 2026 | S | 794 | $506.8377 | D | 325,149 | I | by Trust |
| Common StockF15,F2 | Sep 9, 2026 | S | 506 | $507.6775 | D | 324,643 | I | by Trust |
| Common StockF2 | Sep 9, 2026 | S | 200 | $509.00 | D | 324,443 | I | by Trust |
| Common Stock | holding | — | — | — | 40,513 | D | ||
| Common Stock | holding | — | — | — | 166 | I | by Spouse | |
| Common StockF16 | holding | — | — | — | 249,108 | I | by Trust | |
| Common StockF17 | holding | — | — | — | 45,596 | I | by Trust | |
| Common StockF18 | holding | — | — | — | 8,902 | I | by Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF20,F19 | $117.76 | Sep 9, 2026 | M | 9,500 | D | — | Mar 15, 2027 | Common Stock | 9,500 | 470,910 | I |
Explanation of responses
- F1This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F10This transaction was executed in multiple trades at prices ranging from $502.255 to $503.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11This transaction was executed in multiple trades at prices ranging from $503.26 to $504.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12This transaction was executed in multiple trades at prices ranging from $504.32 to $505.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F13This transaction was executed in multiple trades at prices ranging from $505.32 to $506.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F14This transaction was executed in multiple trades at prices ranging from $506.33 to $507.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F15This transaction was executed in multiple trades at prices ranging from $507.44 to $507.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F16Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F17Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F18Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F19This stock option become exercisable in three equal annual installments beginning on the second anniversary of the grant date. The stock option was granted on March 15, 2019.
- F2Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F20Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F3This transaction was executed in multiple trades at prices ranging from $493.39 to $494.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $495.145 to $496.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $496.15 to $497.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6This transaction was executed in multiple trades at prices ranging from $497.22 to $497.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7This transaction was executed in multiple trades at prices ranging from $498.27 to $499.235. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8This transaction was executed in multiple trades at prices ranging from $499.275 to $500.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9This transaction was executed in multiple trades at prices ranging from $500.335 to $501.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.